The PDZ-ligand and Src-homology type 3 domains of epidemic avian influenza virus NS1 protein modulate human Src kinase activity during viral infection by Bavagnoli, L et al.
The PDZ-Ligand and Src-Homology Type 3 Domains of
Epidemic Avian Influenza Virus NS1 Protein Modulate
Human Src Kinase Activity during Viral Infection
Laura Bavagnoli1, William G. Dundon2, Anna Garbelli1, Bianca Zecchin2, Adelaide Milani2, Geetha
Parakkal1, Fausto Baldanti3, Stefania Paolucci3, Romain Volmer4, Yizeng Tu5, Chuanyue Wu5, Ilaria
Capua2, Giovanni Maga1*
1 Institute of Molecular Genetics National Research Council, Pavia, Italy, 2World Organization for Animal Health, Food and Agriculture Organization and National
Reference Laboratory for Newcastle Disease and Avian Influenza, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy, 3Molecular Virology Unit, Virology and
Microbiology, Fondazione Istituto Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, Pavia, Italy, 4Universite´ de Toulouse, Institut National Polytechnique, Ecole
Nationale de Veterinaire, Unite` Mixte de Recherche 1225, Interactions Hotes-Agents Pathoge`nes, Toulouse, France, 5Department of Pathology, University of Pittsburgh,
Pittsburgh, Pennsylvania, United States of America
Abstract
The Non-structural 1 (NS1) protein of avian influenza (AI) viruses is important for pathogenicity. Here, we identify a
previously unrecognized tandem PDZ-ligand (TPL) domain in the extreme carboxy terminus of NS1 proteins from a subset
of globally circulating AI viruses. By using protein arrays we have identified several human PDZ-cellular ligands of this novel
domain, one of which is the RIL protein, a known regulator of the cellular tyrosine kinase Src. We found that the AI NS1
proteins bind and stimulate human Src tyrosine kinase, through their carboxy terminal Src homology type 3-binding (SHB)
domain. The physical interaction between NS1 and Src and the ability of AI viruses to modulate the phosphorylation status
of Src during the infection, were found to be influenced by the TPL arrangement. These results indicate the potential for
novel host-pathogen interactions mediated by the TPL and SHB domains of AI NS1 protein.
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Introduction
Avian influenza (AI) viruses pose significant threats to both
animal and human health. Approximately 200 million birds have
died or have been culled worldwide as a result of AI. In addition,
since 1997, AI viruses of the H5 or H7 subtype have crossed the
species barrier and caused fatal disease in humans [1,2,3,4]. These
events, in addition to the emergence of the triple-reassortant of
avian and swine genes H1N1v as a pandemic virus in 2009 [5],
warn us of the potential generation of another human pandemic
virus. Thus, understanding the pathogenic determinants of AI
viruses and their modifications in the course of natural epidemics is
important for the identification of natural reservoirs of potential
pandemic viruses. The NS1 protein of AI viruses is an important
pathogenicity determinant [6,7], and was shown to possess a PDZ-
ligand (PL) motif, enabling it to interact with a wide range of cellular
proteins [8–11] and influencing pathogenicity [12–14]. One of the
most severe AI outbreaks in European poultry was caused by an
H7N1 subtype virus between 1999 and 2001. Longitudinal analysis
of low pathogenic (LP) and high pathogenic (HP) AI H7N1 isolates
circulating during the outbreak [15], revealed that the H7N1 LP
viruses at the beginning of the epidemic had a full length NS1
protein (F3 protein, Fig. 1 a), while the HP isolates circulating
during the peak weeks showed a truncation of the last C-ter six
amino acids (aa) of NS1 (F4D225–230 protein, Fig. 1 a). At the end of
the epidemic, the majority of circulating AI viruses were LP isolates,
with a C-ter deletion of 10- aa in the NS1 protein (F6D221–230
protein, Fig. 1 a). H5 and H7 AI viruses are the only subtypes
causing high pathogenic infections in poultry and to possess the
potential to be transmitted to humans. Thus, changes in the
pathogenic potential of these AI viruses during extensive epidemics
might represent a potential threat to human health. Since the
observed truncations in H7N1 NS1 protein spanned the PDZ-
ligand (PL) domain, which has been documented to influence
pathogenicity through the interaction with host cell proteins, we
investigated whether these truncations might alter the ability of the
AI NS1 protein to interact with human host factors.
Results
Identification of a novel tandem PDZ-ligand domain in
epidemic H7N1 virus
PL domains are specific sequences, usually located in the last 5
to 6- C-ter aa of cellular proteins, that recognize the structural
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protein-protein interaction module PDZ [16,17]. A map of the
amino acid specificity for PL domains has been derived starting
from the physico-chemical characteristics of the aa present with
higher frequency in the PL sequences recognized by different PDZ
domains [18]. Based on this specificity map, we identified in the
last 12- aa of the H7N1 NS1 proteins two partially overlapping PL
motifs (indicated as PL domain I and II, respectively, in Fig. 1 a
and b). BLAST search using the consensus sequence for this novel
tandem PL (TPL) domain as bait retrieved 427 avian influenza
NS1 sequences, out of more than 6,000 present in the database,
possessing this previously unrecognized tandem PL (TPL) domain
(Table S1). The geographical distribution (based on the country of
isolation as reported in the database) and the phylogenetic tree of
these viruses (based on their NS1 protein sequences), are shown in
Fig. S1 and S2, respectively. As shown in Fig. 1 c, only five
versions of this domain, each differing from the others by single
aminoacidic substitutions, appear to be present in this restricted
subset of globally circulating AI viruses belonging to different H
and N subtypes. The KRYMARRVESEV domain has been found
in isolates throughout the world, while the KRYMERRVESEI is
reported so far only for a cluster of closely related H7N2 viruses
isolated in North America. The KRYMARRIESEV domain has
been found in isolates from three geographical locations
corresponding to three separate genetic clusters: Canada,
comprising different H and N combinations; Chile, all belonging
to the H7N3 genotype and Germany, with three isolates of the
H10N7 genotype. These German isolates are also the oldest,
dating back to 1949. The Chile isolates cluster genetically close to
the H7N1 viruses of the italian epidemics analysed in this study,
bearing the KRYMARRIESEV domain. The KRYMARRVE-
SEI domain is present in 8 isolates falling in three separate genetic
clusters. Five from China, of the H6N2, H1N1 and H9N2
genotypes, one from Canada, of the H3N8 genotype and two from
US, of the H6N1 genotype. Interestingly, the five Chinese isolates
appear to be genetically close to the oldest H10N7 German
isolates with the KRYMARRIESEV domain. Finally, the
KRFMARRVESEV domain is found only in two isolates from
Japan. Overall, these data indicate that AI viruses carrying
different versions of the TPL domain are circulating worldwide
both in wild birds and domestic poultry.
Identification of cellular ligands for the novel tandem
PDZ-domain of avian influenza NS1
The PDZ binding properties of the novel TPL domain were
tested on protein arrays (Figure 2), representing 58 different types
of human PDZ domains (schematically drawn in Fig. 2 a and 2 i).
As summarized in Fig. 2 h and 2 r, the full length NS1 protein F3
was able to bind 28 human cellular PDZ domains. The 6- aa
naturally truncated NS1 F4D225–230, of the HPAI H7N1 viral
strain, bearing only the PL domain II (Fig. 1 a), interacted with 22
PDZ domains, but only 18 were in common with F3, suggesting
that deletion of the first PL domain also changed the PDZ-domain
binding specificity the protein. When an identical truncation was
engineered into the full length F3 protein to obtain the mutant
DCF3D225–230 (Fig. 1 a) a pattern of interaction similar to
F4D225–230, was observed (Fig. 2 e and 2 o), demonstrating that
the differences between F3 and F4D225–230 NS1 proteins were not
strain specific but dependent on the different PL domain
arrangement. Finally, the naturally occurring 10-aa truncated
NS1 protein F6D221–230, of the LPAI H7N1 with no PL domains
(Fig. 1 a), showed no interaction with the PDZ domains in both
arrays (Fig. 2 d and 2 n), as expected. The F3, F4D225–230 and
F6D221–230 NS1 proteins, although originating from different
isolates, showed .99% identity at the aa level (Fig. 1 a). In order
to compare the PDZ binding characteristics of more distantly
related AI strains, the NS1 protein of the HPAI H5N1 A/HK/
213/03 isolate was tested. The H5N1 NS1 possesses a consensus
PL domain I, but its PL domain II deviates from the consensus due
to a single aa change from a hydrophobic to a positively charged
residue (Fig. 1 a). As shown in Fig. 2 h and 2 r, the H5N1 protein
recognized a set of 20 PDZ domains, of which only 8 overlapped
with the PDZ domains recognized by the F3 protein. Interestingly,
the H5N1 and F4D225–230 NS1 proteins recognized 11 PDZ
domains in common, four of which were specifically bound by
these two proteins and not by F3. Deletion of the PL domain I of
the H5N1 NS1 (protein DCH5N1D220–225), resulted in the
complete loss of interaction with the PDZ domains (Fig. 2 f and
2 q), indicating that its PL domain II was not functional, as
predicted by the sequence. Thus, PDZ-domain binding by AI NS1
proteins requires the presence of at least one functional C-ter PL
domain.
Our array analysis identified the known NS1 interactors
MAGI3 and Dlg1 [9–11] as binding to at least two of the three
NS1 proteins analyzed (Fig. 2 h and r). Seven cellular PDZ
domains, belonging to six different proteins, were also identified,
which were able to bind both the H7N1 NS1 proteins and the
H5N1 NS1, including the known NS1 interactor MAGI1 [11]
(Table S2), Analysis of their PDZ domains allowed the
identification of three blocks of high homology (Fig. S3 a),
defining a PDZ-consensus for the interaction with AI NS1
proteins. The strongest signal from the arrays for the F3,
F4D225–230, DCF3D225–230 and H5N1 NS1 proteins, was observed
with the human Reversion-Induced LIM protein (RIL). To
independently confirm that the interaction observed with the
isolated PDZ domain of RIL on the arrays, reflected true protein-
protein interactions, recombinant F4D225–230 and F6D221–230
proteins were used in pull-down assays with recombinant GST-
RIL expressed in E.coli bound to GSH-sepharose beads. As shown
in Fig. 3, RIL interacted only with F4D225–230 (Fig. 3 a) but not
with F6D221–230 (Fig. 3 b). In addition, one protein (ZO1) was
identified in our array analysis as a specific interactor of the
F4D225–230, DCF3D225–230 and H5N1 (Fig. 2) NS1 proteins. Cell
extracts containing the overexpressed recombinant full length
ZO1 were then incubated with NiNTA-agarose beads in the
absence or in the presence of recombinant his-tagged F4D225–230
NS1. As shown in Fig. 3 c, ZO1 was eluted from the beads only in
the presence of NS1 (lane 3), but not in its absence (lane 6). These
results confirmed that the interactions with the isolated PDZ
domains, detected by the arrays, could also be reproduced with
intact full length proteins.
Figure 1. The NS1 protein of H7N1 avian influenza viruses has a new tandem PDZ-ligand domain. a. Sequence alignment of the NS1
proteins from Italian H7N1 AI isolates and the H5N1 NS1 protein. Equivalent aminoacids are shaded in green; non-equivalent aminoacid are in red.
SHBD, Src-homology type 3 binding domains. PL, PDZ-ligand domain. Alignments were generated with the program ClustalW. b. Comparison of the
amino acid specificities of PL domains I and II of the H7N1 NS1 protein with the consensus specificity map for cellular PL domains. Matching
aminoacids are shown in red. c. Comparison of the amino acid specificities of PL domains I and II of the different AI virus NS1 protein with the
consensus specificity map for cellular PL domains. Matching aminoacids are shown in red. Equivalent aminoacidic substitions with respect to the
H7N1 NS1 protein are shaded in green. Non-equivalent substitutions are shaded in yellow.
doi:10.1371/journal.pone.0027789.g001
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Figure 2. Interaction of avian influenza virus H7N1 NS1 proteins with cellular PDZ domains. a. Schematic representation of the different
PDZ domains present on commercial PDZ Array I (Panomics). Each PDZ domain is present on the membrane in duplicate. Plus signs indicate positive
controls for the anti-histidine antibody used for detection. b. Visualization of the interactions between the H7N1 full length NS1 protein (F3) with the
PDZ domains on Array I. c–g. As in panel b, but with the NS1 F4D225–230, F6D221–230, DCF3D225–230, DCH5N1D220–225 and H5N1 NS1 proteins,
respectively. h. Venn diagram of the interactions detected by the Array I. Violet: common interactions between F3 and F4D225–230 NS1 protein; green,
common interactions between F3 and H5N1 NS1 proteins; cyan, common interactions between the F4D225–230 and H5N1 NS1 proteins; yellow,
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Sequences homologous to the PL domain I of NS1 were present
in several PDZ-binding cellular proteins. A search of the human
protein database with the consensus for the novel PL domain II of
H7N1 NS1, returned 43 proteins bearing matching sequences at
their extreme C-ter. Five of these proteins are reported in the
database to interact with cellular PDZ proteins (Table S3). Among
these cellular PDZ proteins, LIMK1 has been identified in a
genome-wide RNA interference screening, as a host factor
important for influenza virus replication [19]. In addition, the
protein Dlg1 was identifed by our arrays and also independently
shown to bind AI NS1 in published studies [9,10]. The database
query also reported the protein ZO1, which was identified by our
Figure 3. The H7N1 NS1 protein binds the cellular proteins RIL and Src. a. Pull-down analysis of the interaction of human RIL with the H7N1
F3 protein. 10 mg of recombinant his-tagged F3 NS1 was added to glutahione (GSH) sepharose beads in the presence (lanes 2–4) or in the absence
(lanes 5–7) of 10 mg of recombinant human GST-tagged RIL. Beads were washed with PBS16. Bound proteins were luted with 10 mM GSH, separated
on SDS-PAGE and detected by western blot with anti-GST (RIL) or anti.his (NS1) antibodies. W, wash; E, elution; B, beads. Lane 1, control western blot
with input proteins. b. As in panel a, but with the F4D225–230 protein. c. Pull-down of recombinant ZO1. Cell lysates overexpressing human ZO1 have
been incubated with NiNTA beads in the presence (lanes 2–4) or in the absence (lanes 5–7) of recombinant his-tagged F4D225–230 protein. W, wash
with 10 mM imidazole; E, elution with 500 mM imidazole; B, beads pellet. d. Recombinant GST-tagged human Src kinase was incubated in the
presence (lanes 2,3) or in the absence (lanes 4, 5) of recombinant his-tagged H7N1 F3 NS1 protein. Proteins were pulled down with his-tag affinity
NiNTA-agarose beads. Anti-Src or anti-his antibodies were used for the detection of Src and NS1, respectively. Lane 1, input proteins. Lanes 2 and 4,
proteins detected in the supernatant in the presence or absence of F3, respectively. Lanes 3 and 5, pulled down proteins in the presence or absence
of F3, respectively. e. Recombinant untagged human Src was added to NiNTA beads in the absence (lanes 1, 4) or in the presence of recombinant his-
tagged F3NS1 (lanes 2, 3; 5, 6) and in the absence (lanes 2, 5) or in the presence of recombinant human GST-tagged RIL (lanes 3, 6). Lanes 1–3: pulled
down proteins. Lanes 4–6, supernatants. Proteins were revealed by immunoblot with anti-Src (upper panel), RIL (middle panel) or his (bottom panel)
antibodies. f. HeLa cell extracts were incubated in the presence (lanes 2, 3) or in the absence (lanes 5, 6) of his-tagged F3 NS1. Proteins were pulled
down with his-tag affinity NiNTA-agarose beads. Lanes 2, 5:, proteins detected in the supernatant in the presence or absence of F3, respectively.
Lanes 3, 6: pulled down proteins in the presence or absence of F3, respectively. Lanes 1, 4: inputs. Antibodies specific for the phosphorylated Y418
(pY418-Src) or Y529 phosphorylated (pY-529-Src) Src residues were used for the detection of the active and inactive Src forms, respectively. Anti-his
antibodies were used for the detection of NS1.
doi:10.1371/journal.pone.0027789.g003
common interactions among the three NS1 proteins. i Schematic representation of the different PDZ domains present on commercial PDZ Array I
(Panomics). Each PDZ domain is present on the membrane in duplicate. Plus signs indicate positive controls for the anti-histidine antibody used for
detection. l. Visualization of the interactions between the H7N1 full length NS1 protein (F3) with the PDZ domains on Array I.m–q. As in panel l, but
with the NS1 F4D225–230, F6D221–230, DCF3D225–230, DCH5N1D220–225 and H5N1 NS1 proteins, respectively. r. Venn diagram of the interactions detected
by the Array I. Violet: common interactions between F3 and F4D225–230 NS1 protein; yellow, common interactions among the three NS1 proteins.
doi:10.1371/journal.pone.0027789.g002
Avian Influenza NS1 Interacts with Src Kinase
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27789
array. Interestingly, a recent study showed that ZO1 was
mislocalized during infection with AI viruses carrying the
consensus -ESEV- PL motif (analogous to PLI), as a consequence
of the interaction between NS1 and Dlg1 [11]. Thus, our data
seem to suggest that AI NS1 can also directly interact with ZO1.
Analysis of these five proteins and their respective ligands listed in
Table S3, using the STRING interaction database [20,21],
revealed that six out of ten proteins were linked through
experimentally confirmed physical interactions (Fig.S3 b). Inter-
estingly, sequence alignment of the PDZ domains of the cellular
interactors of the five proteins listed in Table S3, revealed
significant homology with the PDZ domain of RIL (Table S4),
which emerged as the strongest interactor of avian H7N1 NS1
proteins in our arrays. Collectively, the data of the arrays together
with this bioinformatic analysis, suggest that the PL domain II,
analogous to the one exposed by the 6- aa truncated H7N1 NS1, is
also present in human proteins.
The NS1 protein from H7N1 avian influenza virus
physically interacts with both human RIL and Src proteins
RIL has been shown to interact with the active form of the
tyrosine kinase Src, playing a major role in its downregulation
[22]. Its interaction with NS1 might suggest an involvement of the
viral protein in the RIL-Src axis. Notably, avian NS1 proteins
possess two Src-homology type 3 binding (SHB) domains (Fig. 1
a): SHB domain 1 which mediates the interaction of AI NS1 with
the p85 beta subunit of the PI3K kinase [23], and SHB domain 2
which mediates the interaction with the proteins Crk/CrkL [24].
Interestingly, the SHB domain 2 (-PPLPPK-) of H7N1 NS1 is
immediately upstream to the TPL (Fig. 1 a). Thus, the ability of AI
NS1 to bind Src was tested in pull down assays with recombinant
human Src kinase. As shown in Fig. 3 e, Src was retained on the
Ni-NTA beads only in the presence of his-tagged F3 NS1
(compare lane 3 with lane 5). A molar excess of RIL did not
disrupt the complex between NS1 and Src, so that a ternary
complex was isolated in the absence of the peptide substrate (Fig. 3
f, lane 3). Finally, his-tagged F3 NS1 protein was able to pull down
endogenous Src from HeLa cells extracts (Fig. 3 g, compare lane 3
with lane 6). Probing the pulled down Src (Fig. 3 g, lane 3) and the
input protein (Fig. 3 g, lane 1), with antibodies specific for the
active (pY418) or inactive (pY529) forms of Src, suggested that F3
preferentially associated with the active form of Src.
The H7N1 NS1 proteins stimulate the human Src tyrosine
kinase
The previously unrecognized interaction between NS1 and Src,
prompted us to investigate its functional significance. H7N1 NS1
proteins were not efficient substrates for in vitro Src kinase reactions
(Fig. 4 a), but were able to increase the peptide substrate
utilization efficiency (Vmax/Km
pep ratios) of Src (Table 1). The
F4D225–230 and DCF3D225–230 proteins, bearing PL domain II only,
or the F6D221–230, bearing no PL domains, were more efficient in
stimulating Src (5.5-, 3.1- and 4.8- fold increase of Vmax/Km
pep,
respectively, Table 1) than the full length F3 protein with the intact
TPL (2- fold increase, Table 1). Accordingly, the apparent
affinities of the viral NS1 proteins for Src were higher (lower
absolute Kd
NS1 values) for the F4D225–230, the DCF3D225–230 and
the F6D221–230 proteins (Table 1 and Fig. 4 b). Collectively, these
data show, for the first time, that NS1 can stimulate human Src
and that this ability can be influenced by the PL domain
arrangement.
RIL alone was not a substrate for Src (Fig. 4 a) nor did it
significantly stimulate Src activity (Table 1). When increasing
amounts of RIL were titrated in the kinase reaction, in the absence
or presence of increasing fixed doses of either F4D225–230, or
F6D221–230 proteins (Fig. 4 c), the apparent affinity of Src for RIL
was decreased (increase in the absolute Kd
RIL values, Table 1) by
the presence of the NS1 proteins, suggesting that, in the presence
of the peptide and ATP substrates, the binding of NS1 and RIL to
Src was mutually competitive.
The SH3-binding domain 2 of H7N1 NS1 proteins is
essential for the interaction with Src
RIL has been shown to interact with both the kinase and SH2
domains of Src [22]. We hypothesized that NS1 might bind, instead,
to the SH3 domain of Src through one of its SHB domains. The
general consensus sequences for the AI SHB domains 1 and 2 are -
PØPxxP- and –PPØPxK/R-, respectively, where Ø indicates
hydrophobic aminoacids. Sequence analysis (Fig. 4 d) showed that
the SHB domain 1 is generally conserved among influenza viruses,
while the SHB domain 2 is more variable. The -PPLPPK- sequence is
present in the 1918 H1N1 ‘‘Spanish flu’’ virus (A/Brevig_Mission/
1918), while the most recent H1N1v 2009 pandemic virus, as well as
the human H1N1 and H3N2 seasonal strains, show different aa
substitutions, leading to the loss of conserved residues. The H5N1
NS1 protein carries aminoacid substitutions in its SHB domain 2
leading to the loss of two conserved residues (-LPLPPN-) with respect
to the consensus, while all the H7N1 NS1 proteins retain a perfect
match (-PPLPPK-). We cloned the NS1 protein from two seasonal
H3N2 human influenza isolates of the 2007 epidemic (VR9220 and
VR9240), bearing an intact SHB domain 1, but with one aminoacid
substitution in a conserved Pro of SHB domain 2 (-PPØTPK-), an
compared them to the F3 and H5N1 NS1 protein for their ability to
stimulate Src. No stimulation of Src was observed by the full length
H5N1 NS1, or by the two H3N2 NS1 proteins (Fig. 4 e), suggesting
that an intact SHB domain 2 was required for the interaction.
The SH3-binding domain 2 of H7N1 NS1 proteins is a
general interaction module for cellular tyrosine kinases
Since the SHB domain is a general protein module for interaction
with SH3-containing tyrosine kinases, we tested whether AI NS1
could also bind other Src-unrelated tyrosine kinases, as an indication
of SHB domain functionality. Indeed, H7N1 NS1 was able to
stimulate the in vitro activity of the human tyrosine kinase c-Abl (Fig. 4
f). When similar experiments were carried out with the full length
H5N1 NS, or the two H3N2 human influenza NS1 proteins, no
stimulation of the activity of Abl (Fig. 4 f), was observed, further
confirming the importance of an intact -PPØPxK/R- consensus SHB
domain 2 for this interaction. The SHB domain 2 sequence -
PPLPPK- was present in 326/427 (76.3%) of the AI viral isolates
identified in this study bearing the TPL domain. Alignment of the
different SHB domain 2 sequences found in all the 427 AI isolates, to
the consensus -PPØPxK- sequence (Table S1), indicated a degree of
conservation between 93% and 100% for all the essential positions,
with the exception of the Pro in fourth position, which showed a non-
conservative substitutions with a Ser in 16% of the isolates (Table S1).
This residue has been previously recognized as a host marker in
pandemic viruses [25]. It is possible that the different degree of
conservation in the SHB domain 2 among mammalian and AI
viruses, reflects different selective pressures.
The activation state of cellular Src during infection is
differently modulated by H7N1 viruses expressing the full
length or the truncated NS1 protein
Endogenous Src is present as an active or inactive protein in the
cell, depending on its phosphorylation status [26,27]. A precise
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Figure 4. The H7N1 NS1 protein stimulates Src activity through its SH3-binding domain. a. In vitro Src kinase reactions were carried out in
the absence or presence of the Src peptide (white bar) or increasing amounts of F3 (light grey bars), F6D221–230 (black bars) or human RIL proteins
(dark grey bars) as substrates. Activity is expressed as relative to the reaction with the Src peptide substrate (100%). Values are the means of duplicate
experiments. Error bars represent6SD. b. Dose-dependent increase of the affinity of Src for its peptide substrate as a function of NS1 concentrations.
Apparent peptide affinity values determined in the absence (Km
pep) or in the presence (Km
pep
NS1) of NS1, were used to calculate the relative affinity
increase (1-Km
pep/Km
pep
NS1). Values are the means of calculations from three independent determinations of the affinity constants. Error bars are6SD.
c. Stimulation of Src activity, expressed as the increase in the ratio of enzyme velocity in the presence (vRIL) and in the absence (v) of increasing
amounts of RIL alone (circles) or in the presence of fixed doses of F4D225–230 (triangles), or F6D221–230 (squares) NS1 proteins. Values are the means of
three independent replicates. Error bars are 6SD. d. Sequence alignment of the SHB domains 1 and 2 of different influenza viruses. Conserved
residues with respect to the consensus are shaded in grey, non-synonimous substitutions in conserved residues are in boxed in black. e. Stimulation
of Src catalytic efficiency (Vm/Km
pep) by H7N1 F3 NS1, H5N1 NS1, or the H3N2 2007 epidemic human isolates VR9220 and VR9240 NS1. Each bar
represents the mean value of three independent determinations of the Vm/Km
pep. Error bars are6 S.D. f. In vitro Abl kinase reactions were performed
in the presence of the specific Abl peptide substrate and in the absence (white bars) or in the presence of increasing amounts of F3 (grey bars), H5N1
NS1 (black bars) or human influenza H3N2 NS1 (light rey bars) proteins. Experiments were in triplicate. Error bars represent 6SD.
doi:10.1371/journal.pone.0027789.g004
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balance of the different phosphorylated forms is essential for
cellular homeostasis. The cellular protein RIL has been shown to
be important for the maintenance of the active vs. inactive Src
equilbrium [22]. The physical and functional interaction of the
H7N1 NS1 proteins with both RIL and Src, may suggest that the
activation state of Src within the cell during the infection might be
influenced by the ability of H7N1 NS1 proteins to interact with
RIL. To start addressing this question, the phosphorylation status
of endogenous Src was then assessed, through western blotting
analysis with antibodies specific for the active (pY418) or inactive
(pY529) forms of Src, in A549 (human alveolar basal epithelial
cancer) cells infected with the r977 or the r4426 recombinant viral
strains (Fig. 5 a, b). These viruses contain the full length F3 (r977)
and the truncated F6D221–230 (r4226) proteins, respectively, with an
A/turkey/Italy/977/99 H7N1 backbone (see also Fig. 1 a).
Intensities of each band were normalized to the intensity of actin
revealed on the same membrane. The resulting relative intensity
units (RIU) were used to calculate the Src active/Src inactive
ratios, which are shown in Fig. 5 c). The virus expressing full
length F3 NS1 protein, caused a statistically significant increase
(p,0.05) of the active form of Src in the soluble fraction, while the
virus expressing the truncated F6D221–230 protein did not
significantly change the balance between active and inactive Src.
In addition, while the full length F3 NS1 was detected in both the
soluble and insoluble fractions, the F6D221–230 protein was
selectively retained in the insoluble fraction only (Fig. 5 d),
suggesting that the 10- aa deletion of F6D221–230 NS1 changed the
intracellular distribution of the protein in the infected cells. This is
consistent with the observation that C-ter truncations in H7N1
NS1 protein cause its recruitment to the nucleolar compartment
[28]. No changes in the intracellular distribution of RIL were
observed (Fig. 5 d). Overall, these result indicate that the
truncation occurring in the F6D221–230 NS1 protein, while not
affecting its ability to interact and activate Src kinase in vitro,
prevents Src activation in the infected cells, suggesting an
important role of the PL domain in mediating NS1 association
with Src, in vivo, presumably through interaction with the Src
regulator RIL.
Discussion
Interaction of AI NS1 with the PDZ domains of cellular
proteins has been shown to influence viral pathogenicity. H5N1
NS1 interacts with the cellular PDZ proteins Scribble and Dlg,
altering the JAK/STAT signalling pathway and protecting
infected cells from apoptosis [9–11]. However, the avian PL
sequence (-ESEV-) seems to affect viral pathogenesis in a strain-
and host-dependent manner [13,14]. For example, while reintro-
duction of the fully functional 1918 H1N1 PL domain in the NS1
protein of the human H3N2 A/WSN/33 virus, caused enhanced
pathogenicity in mice [12], the same modification of the 2009
H1N1v pandemic virus did not result in enhanced replication or
transmissibility, suggesting that other factors also contribute to
viral pathogenicity [29]. Comparison of the NS1 sequences of
human circulating H1N1 and H3N2 with the new H1N1v
pandemic strain, showed that the last 50–60 aa at the C-ter of NS1
were the less conserved, with aa identity ranging from 41.7 to
67.2%, with respect to the 78–84% aa identity showed at the level
of the entire protein [30]. This suggests that the extreme C-ter
domain (including the PL domain), is subjected to selective
pressure during circulation in novel hosts. Significant host-specific
evolution of the PL domain of swine influenza viruses have also
been suggested by detailed sequence comparison among strains
circulating in different geographical areas in the last .30 years,
indicating host-specific positive selection at the level of the PL
domain, as a result of cross-species transmission [31]. Indeed,
human, equine and swine influenza strains, including the 2009
H1N1v pandemic virus, do not harbour a PL domain, suggesting
that loss of PDZ-binding capability may be one of the steps
involved in adaptation of avian viruses to new hosts [32].
Our phylogenetic analysis of the Italian H7N1 isolates (Fig. S4),
further corroborates this view. We showed that HPAI viruses
circulating in the mid-phase of the epidemic with the F4D225–230
protein, possessing a PL domain II only, arose from LPAI viruses
with full length NS1 F3, harbouring an intact TPL domain. On
the contrary, the LPAI viruses circulating at the end of the
epidemics with the NS1 mutant F6D221–230, bearing a complete
loss of PL domains, originated from a separate viral pool,
suggesting that the 10-aa deletion of F6D221–230 NS1, conferred
a selective advantage over the circulating viruses with the 6-aa
deleted F4D225–230 NS1.
Due to its potential binding to multiple partners, NS1 can
interfere with different cellular pathways on a competition basis,
with some interactions being more stable or more probable than
others. In particular, the AI virus NS1 protein activates the cellular
PI3K kinase by disrupting the interaction between the catalytic
p110 subunit and its negative regulatory subunit p85, through
physical binding to the p110 kinase domain [23].
Here, we showed that AI virus NS1 can interfere with the Src-
RIL regulatory axis in a manner which is influenced by the PL
arrangement. RIL was shown to bind to the phosphatase PTPL1,
allowing its association with the active form of Src [22]. PTPL1
then catalyzes the dephosphorylation of the regulatory residue
Y418 of Src, resulting in kinase inactivation. Our array analysis
showed that full length H7N1 and H5N1 NS1 proteins can
interact through their PL domains with both RIL and PTPL1,
potentially being able to disrupt their interaction. The H7N1 NS1
proteins were also found in this study to bind and stimulate human
Table 1. Kinetic constants for the interaction of Src with its peptide substrate and the NS1 and RIL proteins.
Protein Kd
NS1 (mM) Km
pep (mM) Vmax (pmol6min
21) Vm/Km
pep (pmol6min216mM21) Kd
RIL (mM)
none 106(614) 7(60.5) 0.07 0.0860.02
F3(H7N1) 0.4(60.05) 62(65) 8(60.5) 0.13 n.d.
F4(H7N1)D225–230 0.2(60.04) 25(63) 9.9(60.7) 0.39 0.2360.05
DCF3(H7N1)D225–230 0.25(60.06) 40(65) 9(61) 0.22 n.d.
F6(H7N1)D221–230 0.15(60.04) 23(63) 7.8(60.7) 0.34 0.4760.08
RIL 71(64) 8(61) 0.11 n.a.
n.d., not determined; n.a., not applicable.
doi:10.1371/journal.pone.0027789.t001
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Src kinase through their SHB domain 2, while the H5N1 NS1
protein was not. We showed that loss of PL domain I (as in the
F4D225–230 protein) abolishes interaction with PTPL1 but not with
RIL and Src. Deletion of the entire TPL (as in the F6D221–230
mutant) from the H7N1 NS1, abolishes the interaction with RIL,
but still allows interaction of the viral protein with Src. Thus, the
H7N1 NS1 protein seems to carry the potential for a wider range
of interactions than its H5N1 counterpart, thanks to its TPL and
SHB domain 2.
We propose a model, whereby AI NS1 replaces PTPL1 as the
interacting partner of RIL, preventing Src inactivation. RIL binds
to the SH2 and kinase domain of Src, allowing NS1 interaction
with the SH3 domain. Binding of a protein substrate displaces RIL
from the Src-NS1-RIL complex, whereby NS1 increases the
catalytic efficiency of Src. Loss of the PL domain prevents NS1
interaction with RIL. Interestingly, the F6D221–230 mutant lacking
all PL domains, was found to be sequestered into the insoluble
fraction, upon lysis of infected cells, while the full length F3 NS1
protein was also retained in the soluble part, along with RIL and
Src. The soluble fraction of active Src was indeed specifically
enriched in infected cells expressing full length NS1, but not the
F6D221–230 mutant. Src subcellular localization is subjected to
complex regulation and Src has been found associated not only to
the cytoplasmic side of the plasma membrane, but also to the
endoplasmatic reticulum, Golgi apparatus and cytoskeletal
components [33]. Thus, it is possible that NS1 requires interaction
with RIL to be relocalized at specific cellular compartments
together with Src. Src transduces signals to many cellular
pathways, affecting cell proliferation, cell motility, apoptosis,
immune signalling [34,35]. The exact role of Src activation in
the AI virus replication cycle is still unknown, however, a recent
report showed that IL-1 dependent inflammatory response due to
influenza A viral infection, was dependent on Src activation and
was completely abrogated by PP2 treatment [36]. Thus, it is
tempting to speculate that viruses bearing NS1 proteins able to
upregulate Src activity through the RIL axis, might be expected to
induce a stronger inflammatory response than viruses with NS1
proteins lacking RIL- or Src-binding capabilities. We have shown
Figure 5. The activation state of cellular Src during infection is differently modulated by H7N1 viruses expressing the full length or
the truncated NS1 protein. a. A representative Western blot analysis of the active (Y418 phosphorylated) or inactive (Y529 phosphorylated) forms
of Src in cells infected with the with natural 977 H7N1 strain expressing full length NS1. Intensities normalized to the actin controls are indicated
below each corresponding lane. Mean values for the intensities normalized to actin are indicated below each set as relative intensity units (RIU). b. as
in panel a, but for cells infected with the 4426 virus expressing the F6?221-230 NS1 protein. c. Normalized RIU values for each form, were used to
derive the relative ratios for active vs. inactive Src. Values are the means derived from the western blots of two independent infection experiments, as
exemplified in panels a and b. Each western blot has been loaded with two (mocked) or three (infected) different amounts of crude extract, in order
to obtain replicated measurements for each infection experiment. Error bars are 6S.D. d. Western blot analysis of NS1 and RIL proteins in the cell
extracts used for the experiments shown in panels a and b.
doi:10.1371/journal.pone.0027789.g005
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that NS1 interaction with Src required the SHB domain 2.
Interestingly, human circulating H1N1 and H3N2 strains as well
as the 2009 pandemic H1N1v, all have mutations in the SHB
domain 2, which prevent interaction with Src, suggesting again a
possible host-specific adaptation mechanism.
If loss or inactivation by mutation of the PL domain is a step
involved in adaptation of AI viruses to new hosts, those strains
bearing two PL domains in tandem (TPL), as those reported here,
would present an higher genetic barrier to adaptation. The
comparison of the PDZ-binding specificity of the F3 and F4 H7N1
NS1 proteins, indicated that the set of PDZ domains bound by the
NS1 protein bearing both TPL I and II (F3), was significantly
different from the one recognized by the NS1 protein bearing TPL
II only (F4). This suggests that these two domains are not identical
and that deletion of the TPL I can alter the network of interactions
between AI NS1 and cellular PDZ proteins, possibly affecting
pathogenesis. Thus, AI viruses bearing a TPL may represent a
potential threat in case of cross-species infections [37]. Interest-
ingly, by sequence alignment, we have found the novel TPL
domain arrangement also in a group of H5N1 isolates circulating
in China (A/Env/HK/437/99, acc. no. Q9EA66, Q9EA72,
Q77NF2, Q9DGY0), antigenically and genetically related to the
H5N1 virus responsible for the human AI outbreak of 1997 [38].
Thus, the potential interaction of their NS1 proteins with essential
human cellular pathways warrants further investigation.
A therapeutic strategy that can reduce the emergence of viral
resistance towards antiviral drugs is the selective targeting of host
factors required for viral replication. We have recently provided a
successful example of such an approach towards HIV-1 infection
[39]. In this study, by analyzing the occurrence of AI-like PL
domains in human PDZ-binding proteins, a restricted number of
proteins potentially mediating host-pathogen relationships in AI
virus replication have been identified. These findings might be
further expanded to identify novel anti-influenza targets and
drugs.
Materials and Methods
Chemicals
Labelled [gamma-32P]- ATP was from GE Healthcare. All
other chemical reagents were from Merck and Fluka.
Enzymes and proteins
Baculovirus-produced recombinant purified active human Src
and Abl were purchased from Upstate (Lake Placid, NY).
Cloning of NS1 proteins and construction of deletion
mutants
The genes of NS1 proteins used in this study were: NS1 wild
type (225 aa) from avian influenza virus A/HK/213/03 H5N1,
NS1 wild type (230 aa) from A/Turkey/Italy/977/99 H7N1 (F3),
NS1 containing the deletion of 225–230 aa from A/Turkey/Italy/
4580/99 H7N1 (F4D225–230), NS1 containing the deletion of 220–
230 aa from A/Turkey/Italy/4426/00 H7N1 (F6D221–230). The
ns1 genes were amplified using a standard RT-PCR protocol and
cloned into the pQE30 expression vector. For detailed cloning
procedures see the Supplementary Information.
Reverse genetics
The recombinant viruses r977 and r4426 expressing the full
length F3 and the truncated F6D221–230 NS1 respectively were
generated in an A/Turkey/Italy/977/1999 genetic background as
described [14].
Protein purification
The expression of His6-NS1 proteins was induced in BL21 (DE3)
cells transformed with the expression vector pQE30-NS1 as described
in Supplementary Information. Soluble His6-tagged NS1 proteins
were purified by chromatography through an FPLC-Ni-NTA
column as described (see Supplementary Information). Recombinant
GST-RIL was purified from the pGEX-5x-1-RIL expressing vector
(15) by gluthathione-conjugated GSH-sepharose beads (GE Health-
care) as described in Supplementary Information.
Pull down assay
Recombinant GST-tagged RIL (10 mg) was bound to GSH-
sepharose beads. His-tagged recombinant F3 or F4 proteins
(10 mg) were added in PBS16and incubated at 4uC O/N. Bound
proteins were recovered by centrifugation, eluted with 10 mM
glutathione and resolved by SDS-PAGE, followed by Western
blotting with anti-His6 and anti-GST IgG antibodies.
Recombinant His-tagged F3 (20 mg) coupled to NiNTA-agarose
beads in PBS 16were mixed with 10 mg of recombinant GST-tagged
human Src kinase and incubated at 4uC O/N. Bound proteins were
recovered by centrifugation and resolved by SDS-PAGE, followed by
Western blotting with anti-His6 and anti-Src rabbit IgG antibody (for
detailed protocol see Supplementary Information).
Alternatively, recombinant His-tagged F3 (20 mg) coupled to
NiNTA-agarose beads in PBS 16 were mixed with HeLa cell
lysate for 1 h at 4uC. Pulled down proteins were resolved on SDS-
PAGE 10% gels. Samples were analyzed by Western blotting
using either primary rabbit anti-Src [pY418] (to detect the active
form of Src kinase) or anti-Src [pY529] (to detect the inactive form
of Src kinase) antibodies (Biosource). For detailed protocol see
Supplementary Information.
PDZ domain arrays
PDZ domain arrays representative of 58 human PDZ domains
(Array I and III, Panomics) were used. Each membrane was
incubated with the manufacturer’s Wash Buffer for 30 min and
then blocked with the manufacturer’s Blocking Buffer 16, and
shaken at room temperature for 2 h. After two washes with Wash
Buffer 16, the membranes were placed on a shaker and incubated
with 15 mg/ml of each NS1 proteins, diluted in Blocking Buffer
16, for 2 h at room temperature. After incubation, the
membranes were washed three times with Wash Buffer 16, and
incubated with Anti-Histidine-HRP-conjugated for 2 h at room
temperature. For identification of the spots detection solution was
prepared according to the manufacturer’s specifications.
Kinase Assays
Src activity was measured in a filter-binding assay using a
commercial kit (Src Assay Kit, Upstate), according to the
manufacturer’s protocol, using the specific Src peptide substrate
[KVEKIGEGTYGVVYK] and in the presence of 0.012 mM of
Src and 0.160 pmol of [c-32P]ATP. Unlabelled ATP was added to
reach the final concentrations as indicated in the figure legends.
Abl activity was measured in a filter-binding assay using an Abl
specific peptide substrate (Abtide, Upstate), 0.012 mM
[c-32P]ATP, 0.022 mM c-Abl. Reaction conditions were (in a
final volume of 10 ml): 25 mM Tris-HCl pH 7.5, 1 mM DTT.
Unlabelled ATP/Mg++ (1:1 M/M) mix was added to reach the
final ATP concentration of 100 mM. Reactions were incubated for
10 min at 30uC. Samples (9 ml) were spotted on paper cellulose
filters which were washed according to the manufacturer’s
protocol. Filter-bound radioactivity was measured by liquid
scintillation with a Microbeta-Trilux apparatus (Perkin-Elmer).
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Viral infection
For the western blot experiments, 16105 human alveolar basal
epithelial cancer cells (A549, ATCC no. CCL-185) were infected
following standard protocols for 48 hrs at an M.O.I. of 1 with
either recombinant virus r977 or r4426 with the addition of
1.5 mg/ml of TPCK trypsin.
Cell lysis
A549 cells were harvested following infection and incubated on
ice for 30 min in 50 mM Tris-HCl pH 8.0, 0.1% SDS, 0.35 M
NaCl, 0.25% Triton in the presence of protease inhibitor cocktail.
Cells were then centrifuged 10 min at 4uC (200006g). The
supernatant was kept as the soluble fraction. The pellet was
extracted by sonication (365 s) in 0.5 M NaCl, supplemented with
16Laemli Buffer, heated 5 min at 100uC, centrifuged (30 min
200006g) and the supernatant kept as the insoluble fraction.
Kinetic Analysis
The kinetic constants were derived by fitting the experimental
data to the appropriate rate equations, as detailed in supplemen-
tary Information. Curves were obtained by non-linear least
squares computer fitting of the data to the equations with the
program GraphPad Prism 3.0.
All sequence alignments were generated with the tool
CLUSTALW (http://www.ebi.ac.uk/Tools/clustalw2/). Similar-
ity searches were performed with the tools BLAST (http://www.
expasy.ch/tools/blast/) and PROSITE (http://www.expasy.ch/
tools/scanprosite/). Network interaction analysis was performed
by STRING (http://string-db.org/).
Supporting Information
Figure S1 Geographical distribution of th AI isolates
bearing the novel TPL domain. The map is based on the
locations of the reported identification of the different isolates
present in the database. The different versions of the TPL domain
are indicated with different colours. Due to sampling bias, the
frequency of each variant in the database does not necessarily
correlate with the actual natural distribution of the different viruses.
(PDF)
Figure S2 Phylogenetic tree of the AI viral isolates
bearing the novel TPL domain. The tree was generated
starting from the aminoacidic sequences of 195/427 isolates
present in the database, including all the sequences of the
KRYMERRVESEI, KRYMARRIESEV and KRYMARRVE-
SEI groups and 97/325 sequences of the most common
KRYMARRVESEV group. Isolates with the same TPL domain
version are grouped by coloured frames. The tree was generated
by the platform Phylogeny.fr (http://www.phylogeny.fr/) with the
program sMUSCLE, Gblocks and PhyML (Dereeper A., et al.
Nucl. Acids Res. 2008, 36, Web server issue W45-9). Tree was
drawn by the program TreeDyn.
(PDF)
Figure S3 Analysis of cellular PL type II domains.
Sequence alignment of the human cellular PDZ-domains interact-
ing with H7N1 and H5N1 NS1 proteins, identified by protein
arrays analysis. Blocks of identical residues (in red) are highlighted in
yellow. Similar aminoacids are highlighted in green. The derived
consensus is shown (in red) at the bottom of the panel. Ø,
hydrophobic residues; ¥, aliphatic residues. b. STRING interaction
network of the cellular proteins bearing a PL domain type-II
(KIF13B, CADM1, CNTAP-2) and their respective PDZ-ligands
(DLG1, MPP3, CASK). Colour coded connecting lines as per
STRING nomenclature are as follows: purple, experimentally
proven physical interactions; green, co-cited in the same article
(PubMed); cyan, linked through functional homology. c Expanded
STRING interaction network built from the cellular proteins
(circled in red) with PL domain II (KIF13B, CNTAP-2, CADM1)
and their respective PDZ ligands (DLG1, CASK, MPP3). The
thickness of the connecting lines is proportional to the STRING
score (likelihood of interaction).
(PDF)
Figure S4 Phylogenetic tree of the NS1 proteins from
H7N1 AI viruses isolated during the Italian 1999–2001
epidemic. The tree was generated using the neighbour-joining
method as implemented by the MEGA4 program (Tamura K. et
al. (2007), Mol. Biol. Evol. 24, 1596–1599). Green circles identify
isolates with a full length (230 aa) protein; yellow triangles identify
isolates with a 6 aa C-ter truncation (D225–230); red squares
identify isolates with a 10 aa C-ter truncation (D221–230).
(PDF)
Table S1 TPL an SHB2 domains of AI viruses grouped
according to the corresponding hemagglutinin (H)
subtypes.
(PDF)
Table S2 Cellular PDZ proteins interacting with H7N1
and H5N1 NS1 proteins.
(PDF)
Table S3 PDZ-binding human proteins bearing NS1 PL
II homologous domains and their cellular ligands.
(PDF)
Table S4 Alignment of human PDZ domains interacting
with cellular PL domain II-homologs, to the PDZ domain
of the human protein RIL, interacting with AI NS1.
(PDF)
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